Hershey margin recovery expected to begin in Q2, but Jefferies stays on sidelines over volume concerns

Jefferies expects Hershey’s Q2 gross margin to begin meaningful recovery as higher-cost cocoa inventory from last year cycles out, forecasting ~300 bps of year-over-year gross margin expansion. However, it maintained a Hold rating due to ongoing weakness in consumer demand and limited evidence of improving sales volumes. Net impact is a cautious outlook: margins should improve, but topline recovery remains uncertain.

Analysis

The near-term setup is a classic margin-vs-volume tradeoff: cocoa deflation or inventory roll-off can lift reported gross profit quickly, but that does little for equity value if unit demand is still deteriorating. In other words, this is more likely to be a quality-of-earnings story than a real growth inflection, so any multiple expansion should be capped unless scanner data or retailer restocking turns. For HSY, the market will likely reward the first clean gross-margin print, then refocus on whether the company can defend share without re-accelerating promotions.

The second-order effect is that margin relief probably gets competed away across the chocolate aisle. Peers with broader snack portfolios or more international mix may use the same input tailwind to hold shelf prices and steal share, while smaller premium-chocolate brands remain most exposed to consumers trading down. If HSY raises prices less aggressively to protect volume, the benefit leaks to retailers and private label rather than showing up in earnings power.

Contrarianly, the consensus may be over-anchored to the margin recovery and underpricing the duration risk: if volumes stay soft through 2Q and 3Q, the market could start treating this as peak EPS rather than trough margins. The key falsifier is not cocoa costs but volume cadence; if depletions remain negative after the gross-margin step-up, the stock likely loses its rerating case even with better reported profitability. That makes this a months-long catalyst, not a multi-year revaluation, unless demand evidence improves.

Key Decisions for Investors

• Avoid chasing HSY into the first gross-margin print; treat any 2Q strength as a tactical event, not a structural long, unless volume data turns positive within 30-60 days.
• If HSY rallies on margin relief, consider a tactical short or put-spread hedge against the move, with the thesis invalidated by a clear re-acceleration in organic volume or retailer replenishment commentary.
• Pair trade: long HSY / short a broader consumer staples basket only if margin expansion is the dominant driver in 2Q; otherwise prefer no trade because weak demand makes the relative case fragile.
• Watch MDLZ and premium-snack peers for share-transfer evidence; if HSY is protecting margin by spending less on promotions, competitors with stronger mix may be the real beneficiaries over the next 1-2 quarters.
• Set a catalyst alert for 2Q scan data and management commentary on elasticity; if volumes stay negative despite 300 bps gross-margin expansion, reduce any long exposure quickly.